A citation-based method for searching scientific literature

Daniel An, Susana Banerjee, Jung-Min Lee. Cancer Treat Rev 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Ran Tang, Chao Yang, Xiang Ma, Younan Wang, Dakui Luo, Chi Huang, Zekuan Xu, Ping Liu, Li Yang. Oncotarget 2016
58
100

Treatment of epithelial ovarian cancer.
Lindsay Kuroki, Saketh R Guntupalli. BMJ 2020
27
100

Lin28: primal regulator of growth and metabolism in stem cells.
Ng Shyh-Chang, George Q Daley. Cell Stem Cell 2013
308
100


Advances in ovarian cancer therapy.
Alexander J Cortez, Patrycja Tudrej, Katarzyna A Kujawa, Katarzyna M Lisowska. Cancer Chemother Pharmacol 2018
183
100

High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer.
Yao He, Hui Wang, Meina Yan, Xinxin Yang, Rong Shen, Xiaoge Ni, Xiaokun Chen, Peifang Yang, Miao Chen, Xiaodong Lu,[...]. Mol Med Rep 2018
12
100

Upstream and downstream mechanisms for the promoting effects of IGF-1 on differentiation of spermatogonia to primary spermatocytes.
Guoqiu Shen, Rongpei Wu, Bo Liu, Wenhan Dong, Zhong Tu, Jiarong Yang, Zhe Xu, Tiejun Pan. Life Sci 2014
24
100

Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
Man Xiao, Jing Cai, Liqiong Cai, Jinghui Jia, Lisha Xie, Ying Zhu, Bangxing Huang, Dongdong Jin, Zehua Wang. J Ovarian Res 2017
33
100

Multimodal Treatment of Primary Advanced Ovarian Cancer.
Michael Friedrich, Dominique Friedrich, Clayton Kraft, Christoph Rogmans. Anticancer Res 2021
1
100

miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.
Yanan Wang, Wei Bao, Yuan Liu, Shiyu Wang, Shengjie Xu, Xi Li, Yanli Li, Sufang Wu. Cell Death Dis 2018
42
100

Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination.
Shuo Yang, Janaki Chintapalli, Lakshmi Sodagum, Stuart Baskin, Ashwani Malhotra, Krzysztof Reiss, Leonard G Meggs. Am J Physiol Renal Physiol 2005
48
100

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Kathleen N Moore, Angeles Alvarez Secord, Melissa A Geller, David Scott Miller, Noelle Cloven, Gini F Fleming, Andrea E Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M Oza,[...]. Lancet Oncol 2019
142
100

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.
Nikolaos A Dallas, Ling Xia, Fan Fan, Michael J Gray, Puja Gaur, George van Buren, Shaija Samuel, Michael P Kim, Sherry J Lim, Lee M Ellis. Cancer Res 2009
383
100

Cell invasion through basement membrane: the anchor cell breaches the barrier.
Elliott J Hagedorn, David R Sherwood. Curr Opin Cell Biol 2011
55
100

LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells.
Jianbiao Zhou, Siok-Bian Ng, Wee-Joo Chng. Int J Biochem Cell Biol 2013
111
100

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.
U A Matulonis, R Shapira-Frommer, A D Santin, A S Lisyanskaya, S Pignata, I Vergote, F Raspagliesi, G S Sonke, M Birrer, D M Provencher,[...]. Ann Oncol 2019
165
100

Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.
X Sun, C Xu, S-C Tang, J Wang, H Wang, P Wang, N Du, S Qin, G Li, S Xu,[...]. Cancer Gene Ther 2016
56
100

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
Bodo Brueckner, Carlo Stresemann, Ruprecht Kuner, Cora Mund, Tanja Musch, Michael Meister, Holger Sültmann, Frank Lyko. Cancer Res 2007
335
100

Cell migration and invasion assays.
Karwan A Moutasim, Maria L Nystrom, Gareth J Thomas. Methods Mol Biol 2011
33
100

The Epithelial-Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer.
Hanmin Wang, Evgeny Chirshev, Nozomi Hojo, Tise Suzuki, Antonella Bertucci, Michael Pierce, Christopher Perry, Ruining Wang, Jeffrey Zink, Carlotta A Glackin,[...]. Cancers (Basel) 2021
2
100

Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer.
Christen A Khella, Gaurav A Mehta, Rushabh N Mehta, Michael L Gatza. J Pers Med 2021
3
100

Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis.
Evgeny Chirshev, Nozomi Hojo, Antonella Bertucci, Linda Sanderman, Anthony Nguyen, Hanmin Wang, Tise Suzuki, Emmanuel Brito, Shannalee R Martinez, Christine Castañón,[...]. Mol Oncol 2020
8
100

Defining and Modulating 'BRCAness'.
Andrea K Byrum, Alessandro Vindigni, Nima Mosammaparast. Trends Cell Biol 2019
47
100

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.
B J Reinhart, F J Slack, M Basson, A E Pasquinelli, J C Bettinger, A E Rougvie, H R Horvitz, G Ruvkun. Nature 2000
100

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma.
Wenxia Shi, Zili Zhang, Bin Yang, Hua Guo, Li Jing, Tong Liu, Ying Luo, Hui Liu, Yayue Li, Yingtang Gao. Medicine (Baltimore) 2017
30
100

The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes.
Kathleen A Worringer, Tim A Rand, Yohei Hayashi, Salma Sami, Kazutoshi Takahashi, Koji Tanabe, Megumi Narita, Deepak Srivastava, Shinya Yamanaka. Cell Stem Cell 2014
136
100

RAS is regulated by the let-7 microRNA family.
Steven M Johnson, Helge Grosshans, Jaclyn Shingara, Mike Byrom, Rich Jarvis, Angie Cheng, Emmanuel Labourier, Kristy L Reinert, David Brown, Frank J Slack. Cell 2005
100


Let-7a suppresses macrophage infiltrations and malignant phenotype of Ewing sarcoma via STAT3/NF-κB positive regulatory circuit.
Zhongzu Zhang, Yunyun Li, Lu Huang, Qianren Xiao, Xiang Chen, Junlong Zhong, Yiwei Chen, Dong Yang, Zhimin Han, Yong Shu,[...]. Cancer Lett 2016
17
100

Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
Shu Zhang, Curt Balch, Michael W Chan, Hung-Cheng Lai, Daniela Matei, Jeanne M Schilder, Pearlly S Yan, Tim H-M Huang, Kenneth P Nephew. Cancer Res 2008
894
100

Identification of a cancer stem cell in human brain tumors.
Sheila K Singh, Ian D Clarke, Mizuhiko Terasaki, Victoria E Bonn, Cynthia Hawkins, Jeremy Squire, Peter B Dirks. Cancer Res 2003
100

High expression of RAD51 promotes DNA damage repair and survival in KRAS-mutant lung cancer cells.
Jinfang Hu, Zhiguo Zhang, Lei Zhao, Li Li, Wei Zuo, Lei Han. BMB Rep 2019
4
100


Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Neil S Horowitz, Austin Miller, Bunja Rungruang, Scott D Richard, Noah Rodriguez, Michael A Bookman, Chad A Hamilton, Thomas C Krivak, G Larry Maxwell. J Clin Oncol 2015
133
100

ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.
Xuefeng Liu, Virginie Ory, Sandra Chapman, Hang Yuan, Chris Albanese, Bhaskar Kallakury, Olga A Timofeeva, Caitlin Nealon, Aleksandra Dakic, Vera Simic,[...]. Am J Pathol 2012
467
100

let-7 regulates self renewal and tumorigenicity of breast cancer cells.
Fengyan Yu, Herui Yao, Pengcheng Zhu, Xiaoqin Zhang, Qiuhui Pan, Chang Gong, Yijun Huang, Xiaoqu Hu, Fengxi Su, Judy Lieberman,[...]. Cell 2007
100


Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.
Qinglei Gao, Zongyuan Yang, Sen Xu, Xiaoting Li, Xin Yang, Ping Jin, Yi Liu, Xiaoshui Zhou, Taoran Zhang, Cheng Gong,[...]. J Exp Med 2019
55
100

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
100

Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer.
Xuan Jiang, Weihua Li, Xiaoying Li, Huimin Bai, Zhenyu Zhang. Cancer Manag Res 2019
46
100

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
Hua Yang, William Kong, Lili He, Jian-Jun Zhao, Joshua D O'Donnell, Jiawang Wang, Robert M Wenham, Domenico Coppola, Patricia A Kruk, Santo V Nicosia,[...]. Cancer Res 2008
863
100

Cancer metastasis.
L A Dudjak. Semin Oncol Nurs 1992
11
100

MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.
Xiupeng Xu, Zhongyuan Bao, Yinlong Liu, Jing Ji, Ning Liu. Cell Mol Neurobiol 2017
21
100

Unravelling cancer stem cell potential.
Benjamin Beck, Cédric Blanpain. Nat Rev Cancer 2013
480
100

Lin28 is induced in primed embryonic stem cells and regulates let-7-independent events.
Silvia Parisi, Fabiana Passaro, Luigi Russo, Anna Musto, Angelica Navarra, Simona Romano, Giuseppe Petrosino, Tommaso Russo. FASEB J 2017
21
100

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
100

Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02.
Yingdan Huang, Xiuli Hong, Jiasheng Hu, Quanyi Lu. Onco Targets Ther 2017
12
100

Computer control of microscopes using µManager.
Arthur Edelstein, Nenad Amodaj, Karl Hoover, Ron Vale, Nico Stuurman. Curr Protoc Mol Biol 2010
838
100

let-7 microRNAs in development, stem cells and cancer.
Ingo Büssing, Frank J Slack, Helge Grosshans. Trends Mol Med 2008
442
100

Posttranscriptional regulation of microRNA biogenesis in animals.
Haruhiko Siomi, Mikiko C Siomi. Mol Cell 2010
400
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.